JPS6335612B2 - - Google Patents

Info

Publication number
JPS6335612B2
JPS6335612B2 JP50146002A JP14600275A JPS6335612B2 JP S6335612 B2 JPS6335612 B2 JP S6335612B2 JP 50146002 A JP50146002 A JP 50146002A JP 14600275 A JP14600275 A JP 14600275A JP S6335612 B2 JPS6335612 B2 JP S6335612B2
Authority
JP
Japan
Prior art keywords
hepatitis
antigen
virus
liver
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP50146002A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5182720A (en
Inventor
Jee Puroosuto Fuiritsupu
Eru Itensoon Osuwarudo
Aaru Hiruman Moorisu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5182720A publication Critical patent/JPS5182720A/ja
Publication of JPS6335612B2 publication Critical patent/JPS6335612B2/ja
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5768—Hepatitis A
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP50146002A 1974-12-09 1975-12-09 Kanen a kogen Granted JPS5182720A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/530,623 US4029764A (en) 1974-12-09 1974-12-09 Hepatitis A antigen

Publications (2)

Publication Number Publication Date
JPS5182720A JPS5182720A (en) 1976-07-20
JPS6335612B2 true JPS6335612B2 (enExample) 1988-07-15

Family

ID=24114319

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50146002A Granted JPS5182720A (en) 1974-12-09 1975-12-09 Kanen a kogen

Country Status (11)

Country Link
US (1) US4029764A (enExample)
JP (1) JPS5182720A (enExample)
BE (1) BE836390A (enExample)
CY (1) CY1104A (enExample)
DE (1) DE2555169A1 (enExample)
FR (1) FR2293944A1 (enExample)
GB (1) GB1508878A (enExample)
HK (1) HK4081A (enExample)
KE (1) KE3110A (enExample)
MY (1) MY8100308A (enExample)
NL (1) NL189050C (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296024A (en) * 1974-12-09 1981-10-20 Merck & Co., Inc. Human immune serum globulin with high hepatitis A antibody titer
US4017601A (en) * 1975-10-16 1977-04-12 Merck & Co., Inc. Hepatitis A antigen
JPS5283929A (en) * 1976-01-01 1977-07-13 Merck & Co Inc Hepatisis a antigen
NL7711378A (nl) * 1976-11-02 1978-05-05 Merck & Co Inc Werkwijze voor het bereiden van preparaten die dane-deeltjes bevatten.
GB1554811A (en) * 1977-02-23 1979-10-31 Merck & Co Inc Purifying hepatitis b surface antigen
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
PT71739B (en) 1979-09-04 1982-01-26 Merck & Co Inc Process for preparing a cell culture of hepatitis a virus
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
JPS63246335A (ja) * 1987-09-17 1988-10-13 メルク　エンド　カムパニー　インコーポレーテツド 肝炎ｂ抗原
HRP950097A2 (en) 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
US3735004A (en) * 1971-11-01 1973-05-22 Us Army Hepatitis vaccine
NL189051C (nl) * 1974-12-09 1992-12-16 Merck & Co Inc Werkwijze voor het bepalen van antilichamen in een monster.

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
J. IMMUNOL. =1963 *
J. IMMUNOL=1963 *
J. OF IMMUNOLOGY 90=1963 *
JAPAN J. MED. SCI. BIOL. =1966 *
JAPAN J. MED. SCI. BIOL. =1971 *
JAPAN J. MED. SCI. BIOL. 19=1966 *
VIROLOGY 13=1961 *

Also Published As

Publication number Publication date
BE836390A (fr) 1976-06-08
NL7513816A (nl) 1976-06-11
DE2555169A1 (de) 1976-06-10
DE2555169C2 (enExample) 1987-08-13
US4029764A (en) 1977-06-14
JPS5182720A (en) 1976-07-20
HK4081A (en) 1981-02-13
FR2293944B1 (enExample) 1979-03-02
CY1104A (en) 1981-09-11
GB1508878A (en) 1978-04-26
KE3110A (en) 1981-02-20
NL189050C (nl) 1992-12-16
FR2293944A1 (fr) 1976-07-09
MY8100308A (en) 1981-12-31

Similar Documents

Publication Publication Date Title
Norrby A carrier cell line of measles virus in Lu 106 cells
CA2197683C (en) Method for preparing an influenza virus, antigens obtained and applications thereof
Schaffer et al. Purification and properties of poliovirus
Francki et al. Stabilization of capsid structure and enhancement of immunogenicity of cucumber mosaic virus (Q strain) by formaldehyde
Hierholzer Purification and biophysical properties of human coronavirus 229E
Gerber et al. Epstein-Barr virus-induced viral and soluble complement-fixing antigens in Burkitt lymphoma cell cultures
Kitano et al. Morphological, chemical, and biological characterization of Japanese encephalitis virus virion and its hemagglutinin
JPS6335612B2 (enExample)
Fohlman et al. Vaccination of Balb/c mice against enteroviral mediated myocarditis
Norrby Hemagglutination by measles virus: III. Identification of two different hemagglutinins
US4164565A (en) Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
Noble et al. Interactions of components of human rhinovirus type 2 with HeLa cells
US4118478A (en) Vaccine manufacture for active immunization containing hepatitis B surface antigen and associated antigen
US4031203A (en) Hepatitis A antigen
US4118479A (en) Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
Cho et al. The antigen and virus of Aleutian disease in mink
EP0093438B1 (en) Non-a, non-b hepatitis antigen
Eckert et al. Studies on the BAI strain A (Avian myeloblastosis) virus II. Some properties of viral split products
Iltis et al. Demonstration of an avian adenovirus as the causative agent of marble spleen disease
Brown Studies on the antigenic structure of herpes simplex virus
JPH025736B2 (enExample)
Tzianabos et al. Origin and structure of the group-specific, complement-fixing antigen of Rickettsia rickettsii
Polley The use of gamma radiation for the preparation of virus vaccines
US4355019A (en) Hepatitis A testing and growth in tree shrew as animal model
CS223975B2 (en) Method of making the virus vaccines of the spring-summer meningoencephtalitide